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Abstract Using behavioral and genetic information from
the Autism Genetics Resource Exchange (AGRE) data set
we developed phenotypes and investigated linkage and
association for individuals with and without Autism
Spectrum Disorders (ASD) who exhibit expressive lan-
guage behaviors consistent with a motor speech disorder.
Speech and language variables from Autism Diagnostic
Interview-Revised (ADI-R) were used to develop a motor
speech phenotype associated with non-verbal or unintelli-
gible verbal behaviors (NVMSD:ALL) and a related
phenotype restricted to individuals without significant
comprehension difficulties (NVMSD:C). Using Affymetrix
5.0 data, the PPL framework was employed to assess the
strength of evidence for or against trait-marker linkage and
linkage disequilibrium (LD) across the genome. Ingenuity
Pathway Analysis (IPA) was then utilized to identify
potential genes for further investigation. We identified
several linkage peaks based on two related language-
speech phenotypes consistent with a potential motor speech
disorder: chromosomes 1q24.2, 3q25.31, 4q22.3, 5p12,
5q33.1, 17p12, 17q11.2, and 17q22 for NVMSD:ALL and
4p15.2 and 21q22.2 for NVMSD:C. While no compelling
evidence of association was obtained under those peaks, we
identified several potential genes of interest using IPA.
Conclusion: Several linkage peaks were identified based on
two motor speech phenotypes. In the absence of evidence
of association under these peaks, we suggest genes for
further investigation based on their biological functions.
Given that autism spectrum disorders are complex with a
wide range of behaviors and a large number of underlying
genes, these speech phenotypes may belong to a group of
several that should be considered when developing narrow,
well-defined, phenotypes in the attempt to reduce genetic
heterogeneity.
Keywords Autism . Linkage analysis . Association
analysis .Motor Speech Disorder . Autism genes . Ingenuity
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Introduction
Over the past 10 years there has been compelling evidence
supporting a genetic basis for autism using a combination
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of behavioral family studies and genetic linkage and
association studies. However, these studies have produced
results that are often inconsistent and sometimes contra-
dictory (Newbury et al. 2002). Some linkage studies have
identified peaks based on the presence or absence of
autism or autism spectrum disorders (ASD), while other
studies have concentrated on more specific phenotypic and
clinical characterizations such as onset age of first words,
family language history, sex of proband, obsessive
compulsive and ritualistic behaviors, and social skills
[(Alarcón et al. 2002; Auranen et al. 2003; Bradford et
al. 2001; Buxbaum et al. 2004; Liu et al. 2008; Shao et al.
2003); See (Abrahams and Geschwind 2010) for a current
linkage review].
Of particular interest for several research groups has
been the attempt to define and then replicate significant
linkage signals using language-based phenotypes in ASD
probands with the objective of finding genes that are
associated with a specific language-related phenotype.
An area on chromosome 7 (q34–36) has been linked to
both autism and expressive language impairments. A
gene for a contactin associated protein, CNTNAP2, that is
down regulated by FOXP2 and is known to influence early
brain development in humans, has been associated with
both ASD and language (Alarcón et al. 2008; Arking et al.
2008; Vernes et al. 2008). While chromosome 7q
continues to be an area of intense interest for both autism
and language, other linkage signals have been reported
that are also based on language phenotypes in the ASD
population. Alarcón et al. (2005) reported linkage on
chromosomes 3q and 17q using onset of first words and
phrases as the behavioral phenotype while linkage on
chromosome 13q21 was reported by Bradford et al. (2001)
for ASD probands and family members with a history of
language-related problems. Bartlett et al. (2004) identified
linkage in the same region for a sample of families with a
history of Specific Language Impairment (SLI) without
ASD. SLI is a failure to develop language normally
without explanatory factors such as low IQ, gross
neurological impairment, or inadequate environment.
They suggest that although SLI and ASD are distinctly
different disorders, both are genetically complex and may
share specific susceptibility genes or variants of genes.
Spence et al. (2006) stratified expressive language
characteristics into word and phrase speech delay in
ASD probands and family members in an attempt to
better define the language endophenotype and reduce
phenotypic heterogeneity. They found evidence for link-
age in several already identified locations supporting the
idea that more discretely defined characteristics of ASD,
specifically language endophenotypes, may improve lo-
calization of linkage signals and strengthen existing
findings.
Speech and language in ASD
Speech and language impairments constitute a broadly
defined area. In their mildest forms they may be character-
ized by a minor phonological or speech impairment that can
affect speech production and possibly reading ability. On
the more severe end of the language and speech continuum,
a person might be unable to comprehend or process spoken
language and/or be non-verbal or unintelligible. This vast
scope of speech and language disabilities seen in the ASD
population has been documented in detail (Rapin and Dunn
2003; Tager-Flusberg et al. 2005). While some research
supports the notion that there may be multiple relations
among the language problems seen in SLI and autism,
others feel that there is not enough evidence to support a
genetic link (Lindgrin et al. 2009) and that ASD and SLI
are distinctly different disorders that do not share the same
genes.
Previous reports indicate that approximately 50% of all
children with autism never acquire functional language by
middle childhood (Bailey et al. 1996) while more current
estimates place this value as closer to 20% (Lord et al.
2004). Yet little is known about why some individuals,
despite years of intervention, never develop language while
many others develop enough spoken language to commu-
nicate at least minimally. Often the underlying cause is not
clear and may be presumed to be a social/interaction issue.
But what if language processing problems make incoming
verbal information difficult or impossible to understand and
severely limit verbal output? Conversely, what if problems
with speech output make speech very effortful, resulting in
vocalizations that include only vowels sounds or verbal-
izations that are unintelligible to those around them, as in
the case of childhood apraxia of speech (CAS)?
CAS is a motor speech disorder that involves poor motor
planning and results in speech output with compromised
intelligibility ranging from its most severe form of
expressive language production, which is characterized by
very limited consonant production, to full phrase produc-
tion with multiple omissions, substitutions, distortions, and
reversals of speech sounds. While good epidemiologic data
on the prevalence of CAS is lacking, population estimates
derived from referral data suggest that approximately one to
two children per 1,000 are affected with CAS (Shriberg et
al. 1997). There has been limited study of CAS in terms of
its genetic origins, however, in their family and genetic
studies of speech sound disorders, Lewis et al. (2004)
looked at a small sample of children with a diagnosis of
CAS and reported that 59% had at least one parent with
some type of speech sound disorder. Moreover, in 86% of
the families, at least one nuclear family member reported
either a speech sound disorder or a language disorder. In a
recent related study of speech sound disorders Lewis et al.
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(2007) report that 36 of 147 (24%) of parents of children
with speech sound disorders also report similar problems as
children.
Very little has been reported about individuals with
autism whose vocalizations are effortful, unintelligible, or
non-existent. One of the few studies (Gernsbacher et al.
2009) was a retrospective study of children’s oral-motor
skills that compared toddlers with autism to matched
controls. Using videotapes and a detailed questionnaire,
they determined that the quality of oral motor skills during
the early years was associated with the level of speech
intelligibility of the individuals with autism in later years.
Minimally verbal older children had poorer oral motor
skills as toddlers.
In the current Autism Genetic Resource Exchange
(AGRE) dataset, approximately 16% of the individuals
who were evaluated with the Autism Diagnostic Interview-
Revised (ADI-R) (Lord et al. 1994; Rutter et al. 2003) are
non-verbal or minimally verbal at the time of their
evaluations. Another 16% of the individuals in the dataset
have speech that is unintelligible to most people.
Based on our review of the speech and language
characteristics of the subjects in the AGRE database, we
suggest that there is a subset of individuals with and
without ASD who exhibit an expressive language problem
that ranges from being non-verbal to having expressive
language that is unintelligible to others and may actually be
described as a severe motor speech disorder such as verbal
apraxia. As these speech and language behaviors are seen in
only a subset of individuals with autism but also seen in
individuals who do not meet ASD criteria, we investigated




Subjects in this study were obtained from families who are
part of the AGRE database. Unlike many of the other
studies that use the AGRE data for linkage analysis and
require at least two affected siblings with an ASD
diagnosis, we targeted AGRE families who had at least
two individuals who were either non-verbal, minimally
verbal, or who had speech that was unintelligible to others,
regardless of ASD diagnosis.
Responses to specific questions from the ADI-R for all
families with available Affymetrix 5.0 data were used (N=
723). Motor-speech phenotypes were then developed to
explore linkage and association based on the hypothesis
that a subset of individuals on the autism spectrum with
little or no expressive language may be part of a distinct
phenotype common to autism but also potentially common
to other speech and language disorders.
Motor speech phenotypes
Responses by parents and caregivers to the ADI-R were
used as variables to develop the phenotypes used for the
current analyses. The ADI-R is a semi-structured clinical
review for caregivers of children and adults who are
suspected of being on the autism spectrum. The ADI-R
focuses on three areas of behavior: (a) social interaction; (b)
communication; and (c) interests and behaviors that are
stereotyped or restricted and repetitive. Variables from the
Communication Scale were used to develop the current
motor-speech phenotypes and are available in Supplemental
Table 1.
Family members who received the ADI-R (irrespective
of their diagnosis of autism, ASD, or not ASD) were
included in the evaluation of phenotype status. Any family
member who was at least 2 years old and non-verbal or
minimally verbal or was at least 4 years old, verbal, but
very difficult to understand due to poor sound production,
was considered affected for the NVMSD:ALL phenotype
(Non-Verbal Motor Speech Disorder:All). The NVMSD:C
phenotype (Non-Verbal Motor Speech Disorder:Compre-
hension) represented a subset of the NVMSD:ALL pheno-
type and included subjects who were non-verbal or
unintelligible but had at least minimal language compre-
hension (i.e. could at least follow simple directions) as
reported in the ADI-R. Figure 1 reflects the decision
process used to assign affection status for the two motor
speech phenotypes: Non-Verbal, Motor Speech Disorder
(NVMSD:ALL) and Non-Verbal, Motor Speech with
Comprehension (NVMSD:C).
There were 203 families (1,146 individuals) from the
AGRE dataset who had both ADI-R data and Affymetrix
5.0 genotyping data and contained at least two individ-
uals that met our criteria for the NVMSD:ALL pheno-
type. Among the 427 affected individuals for NVMSD:
ALL (79% male), 383 met criteria for the narrow
definition of autistic disorder (AD) based on the ADI-R
and came from 202 families. The mean age at ADI-R
assessment was 98.83 months (s.d. 63.18 months). Of
these 203 NVMSD:ALL families, 135 families (778
individuals) contained at least two family members
who, irrespective of their final autism diagnosis, met
criteria for the NVMSD:C phenotype. Among the 281
affected individuals (80% male), 249 met criteria for the
narrow definition of AD based on the ADI-R and came
from 133 families. For this phenotype the mean age at
ADI-R assessment was 107 .02 months (s .d .
52.40 months) (See Supplemental Table 2). While all
families were used in the Linkage Disequilibrium (LD)
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analyses, 35 NVMSD:ALL families were uninformative
for linkage (19 in the case of NVMSD:C). This was due,
in part, to affected sib-pair families in which the sibs
turned out to be MZ twins.
Genotypes
Genotype data were downloaded from the AGRE site for
all AGRE families with Affymetrix 5.0 data. Data on
443,106 SNPs were available for download. In preparation
for linkage analysis, genotypic data were cleaned for
missingness by marker (≤5% missing retained) and by
individual (≤15% missing retained) (the average missing-
ness rate was 1.5%, while the highest observed rate of
missingness was 11%) and for relationship issues using
RelCheck (Broman and Weber 1998) (no families were
dropped based on RelCheck identified problems). Data
were then screened for Mendel errors and any SNP
showing a Mendel error in a particular family was zeroed
out for the entire family (the average number of Mendel
errors per family was 2,605). However, there were no
families excluded due to excessive Mendelian errors.
In preparation for linkage analysis, markers were
dropped if the minor allele frequency was <5% or if they
showed any signs of departure from Hardy-Weinberg
equilibrium (p<0.05). A subset of these markers was
selected at 0.3 cM intervals resulting in a marker map
comprising 11,100 SNPs.
For LD analyses, SNPs were dropped if the minor
allele frequency was <1%, or if they failed a test of
Hardy-Weinberg equilibrium at the p=10−10 level. This
left a total of 263,334 SNPs in the analysis.
Statistical analyses
Analyses were conducted using the software package
KELVIN that implements the PPL (posterior probability of
linkage) class of models for measuring the strength of
genetic evidence (Huang et al. 2006; Vieland 1998; Vieland
2006). Below we report the PPL, the PPLD (posterior
probability of trait-marker linkage disequilibrium (LD) and
linkage) (Yang et al. 2005) and the PPLD|L (posterior
probability of LD given linkage) (Wratten et al. 2009). We
report genome-wide PPLD results, and use the PPLD|L to
evaluate the evidence for LD under linkage peaks only.
Fig. 1 Individuals who lacked functional language (LEVELL=2) or
had poor speech intelligibility (CARTIC or ARTIC5=2 or 3) were
AFFECTED for the NVMSD:ALL phenotype. If the language level
was fair/good (LEVELL=0 or 1) and current intelligibility was fair/
good (CARTIC=0 or 1) they were labeled UNAFFECTED, otherwise
they were labeled UNKNOWN. Note the CARTIC ADI-R score took
precedence over the ARTIC5 score (as long as ARTIC5 was not 2 or 3
which was established by the previous test) then its contribution was
not considered for this distinction. Only those individuals that were
affected according to the NVMSD:ALL phenotype were evaluated on
their level of spoken language comprehension (NVMSD:C pheno-
type). Individuals with some language comprehension (CCOMPSL=
0, 1 or 2) were labeled AFFECTED, those with very little to no
comprehension (CCOMPSL=3 or 4) were labeled UNKNOWN, and
the remainder as UNAFFECTED. * Note that individuals had to be at
least 2 years old to have a LEVELL score and had to be at least
4 years old to have a CARTIC score but could potentially be older.
Also, if an individual scored 2 for the LEVELL variable, they did not
receive a score for CARTIC or ARTIC5 since they did not produce
enough language to be evaluated.
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The PPL is parameterized in terms of a general
approximating likelihood, and all parameters of the trait
model are then integrated out permitting the use of Bayes’
theorem to compute the posterior probability of the
hypothesis of interest. Hardy-Weinberg equilibrium has
been assumed throughout. The genetic map is based on the
Rutgers Combined Linkage-Physical Map, http://compgen.
rutgers.edu; (Matise et al. 2007) release 10/09/06. Because
KELVIN is at present Elston-Stewart based (Elston and
Stewart 1971), the (multipoint) linkage analyses utilized
LOD scores computed in Merlin (Lander and Green 1987;
Abecasis et al. 2002) as input to PPL calculations (Vieland
1998) using Merlin’s SNP clustering (with r2≥0.2) to
further reduce potential inflation due to residual LD in the
marker map. (We experimented with marker effects by
varying the density of the map, the particular markers
included in the maps, and the r2 threshold for clustering
SNPs, and the results were virtually identical in all cases;
results not shown.)
All analyses shown here utilize a simple dichotomous
trait model, with parameters α (the standard admixture
parameter of Smith (1963) representing the proportion of
‘linked’ pedigrees), p (the disease allele frequency), and the
penetrance vector fi (representing the probability that an
individual with genotype i develops disease, for i=1..3). All
trait parameters are integrated out of the final statistic;
while the gene frequency is integrated over its full range, an
ordering constraint is imposed on the penetrances such that
f1 ≥ f2 ≥ f3. This model provides a robust approximation
for mapping complex traits in terms of the marginal model
at each locus, and because the parameters are integrated
over, no specific assumptions regarding their values are
required. Uniform prior distributions are used for all trait
parameters (with adjustment for the ordering constraint).
This model implicitly allows for dominant, recessive, and
additive models, along with an explicit allowance for
heterogeneity. In secondary analyses, we additionally
allowed for imprinting or other parent-of-origin effects
by allowing the penetrances to depend on the sex of the
transmitting parent.
The PPL is on the probability scale. For instance, a PPL
of 40% means that there is a 40% probability of a trait gene
at the given location based on these data. For biological
reasons, the prior probability of linkage at each location is
set to 2% (Elston and Lange 1975) so that PPLs >2%
indicate (some degree) of evidence in favor of the location
as the site of a trait gene, while PPLs <2% represent
evidence against the location. The prior probability of LD|L
is also set to 2%, so that the prior probability of LD and L
is 0.04%.
The PPL and PPLD are measures of statistical evi-
dence, not decision making procedures; therefore there are
no “significance levels” associated with them and they are
not interpreted in terms of associated error probabilities
(Vieland 1998; Royall 1997; Taper and Lele 2004).
Similarly, no multiple testing corrections are applied to
the PPL or the PPLD, just as one would not “correct” a
measure of the temperature made in one location for
readings taken at different locations (Vieland 1998).
Nevertheless, it may assist readers to have some sense of
scale relative to more familiar frequentist test statistics. In
a simulation of 10,000 replicates of 200 affected sib pairs
per replicate under the null hypothesis (no trait gene at the
location being tested) allowing for the observed pattern of
missing data, PPLs of 5%, 15%, 25%, 50%, and 80% were
associated with Type 1 error probabilities of 0.031,
0.0018, 0.0001, 0.00005, and 0.00001, respectively.
The “null” behavior of the PPLD is moot given the results
of the analysis of the experimental data; however, we note that
in these same 10,000 replicates no PPLD >5% was observed.
Given the sample size, we did not expect to detect LD at
unlinked locations in this small set of families assuming low
genotypic relative risks (RR’s). However, RR’s under linkage
peaks might be expected to be considerably higher in which
case power to detect LD under a linkage peak could actually
be quite good. But power is entirely a function of the
underlying generating model, which remains unknown. For
example, fixing the RR at 2.5 and assuming D’=0.7 between
the trait allele and marker allele, we simulated data under two
different models: (a) we assumed locus homogeneity and
dominant inheritance; (b) we assumed that only 20% of
families carried the associated disease variant and that the
mode of inheritance was recessive. In the first case, 96% of
replicates showed PPLD ≥20%, 88% showed PPLD ≥50%,
and 78% showed PPLD ≥80%. Thus for a model like this,
“power” is excellent in this sample and failure to find LD
under the linkage peaks is an interesting finding (assuming
relatively good marker coverage). In the second case,
however, only 2% of replicates showed PPLDs ≥20%, and
<1% of replicates showed PPLDs ≥50%. Hence if this latter
model is closer to the truth, our failure to detect LD
under the linkage peaks may simply reflect the fact that
the sample is still quite small.
Identifying susceptibility genes
Following the linkage and LD analyses, we used the
Ingenuity Pathway Analysis—IPA software (Ingenuity®
Systems, www.ingenuity.com) to identify potential autism
susceptibility genes that might fall within our linkage
regions. In order to characterize the peaks in our linkage
analyses, we used three definitions of peak endpoints. The
genome-wide PPL values were ranked (based on calcu-
lations done every 1 cM) in ascending order, and the
highest 1%, 2.5%, and 5% PPL scores were used to define
the narrow, intermediate, and broad regions, respectively.
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The narrow regions consisted of PPL values greater than
20%, the intermediate regions were greater than 15%, and
the broad regions were greater than 5%. The genes within
these regions were identified using the UCSC Genome
Browser (NCBI Build 36.1, Kent et al. 2002) and were
analyzed using the Core Analysis in IPA. The Core
Analysis identified the biological functions and/or dis-
eases that were most significant to each linkage analysis.
A right-tailed Fisher’s exact test was used to calculate a
p-value determining the probability that each biological
function and/or disease assigned to that linkage analysis
was due to chance alone. We selected genes with
functions related to Nervous System Development and
Function, Neurological Disorders, Genetic Disorders, and
Psychological Disorders from the list of functions with
significant p-values as possible candidate genes for our
phenotypes.
As a control experiment to assess the uniqueness of our
significant findings, we conducted IPA analyses on ran-
domly selected sets of 645 genes, to model the number of
genes obtained in our intermediate-peak definition analysis
of NVMSD:ALL. We first identified regions of the genome
centered about 2% PPL (evidence neither for nor against
linkage) under the intermediate NVMSD:ALL scan and
randomly selected 645 genes from these regions (Control:
Gene Number—C:GN). However, as a total of only 3,549
genes were present in the areas with approximately 2% PPL
values, this frequently led to partially overlapping sets of
genes. In order to create more independent samples, a
second set of control analyses were also conducted by
selecting 645 genes at random from the entire genome
(Control: Gene Number Genome—C:GNG). We conducted
core analyses on 10 C:GN and 10 C:GNG control datasets
and compared the results to the gene set defined by our
intermediate linkage analysis results of NVMSD:ALL.
Results
Linkage and association
Figure 2 shows genome-wide PPL results for the NVMSD:
ALL phenotype. As can be seen, while most of the genome
shows evidence against linkage (PPL <2%) or very close to
baseline (2%), there are several salient peaks. Table 1
shows all PPL peaks >15% for the NVMSD:ALL pheno-
type. On chromosome 17 there appear to be multiple peaks
(Fig. 3).
Figure 4 shows results by individual chromosomes for
the NVMSD:C phenotype as well as the NVMSD:ALL
phenotype. Because the families that are multiplex for
NVMSD:C are a subset of those that are multiplex for the
NVMSD:ALL phenotype, and because the two phenotypes
themselves overlap by design, we expect correlation in the
genome scans for the two phenotypes in these families.
Moreover, because the NVMSD:C sample is smaller, we
would expect to see smaller linkage signals in this group.
As Fig. 4 shows, across almost all of the genome, this is
exactly what we see: peaks in the same places as in Fig. 2,
but lower. One notable exception to this is on 4p15.2,
Fig. 2 Genome-wide PPL
results for the NVMSD:ALL
phenotype. The PPL is on the
probability scale. Values >2%
represent evidence in favor of
linkage, while values <2%
represent evidence against
linkage.
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where the large peak in the NVMSD:C analysis (PPL=84%
at 45 cM) is quite far from the NVMSD:ALL peak, as
shown in Fig. 5. Also of possible interest are the NVMSD:
C peaks on 21q22.2 (PPL=32% at 55 cM) and 14q24.2
(PPL=20% at 65 cM).
Notably, an allowance for imprinting did not produce
any new peaks or substantially change results at most loci
seen under the non-imprinting analyses. In most cases,
allowance for imprinting slightly depressed peaks. The
exceptions for NVMSD:ALL were on chromosome 17,
where the peaks rise to 86% at 48 cM, 64% at 55 cM, and
47% at 80 cM; in all three cases inheritance from the father
appeared to be silenced. The exceptions for NVMSD:C
were on chromosome 4 (imprinting PPL=97% at 45 cM),
and chromosome 14 (imprinting PPL=31% at 65 cM); in
both of these cases penetrances appeared somewhat higher
for paternal alleles but there was no indication of imprinting
(full silencing) per se.
The PPLD accumulates evidence against LD as well as
in favor of LD. Hence at a SNP that is not in LD with the
trait, the larger the sample size the smaller the PPLD will
become. For this reason, the smaller NVMSD:C data set
yields a noisier GWAS plot around baseline. As discussed
above, we were not expecting to see large PPLDs in a
sample this size, and indeed, we do not see any.
(Supplemental Figure 1)
Of greater interest than the genome-wide PPLDs,
however, are the PPLD|L results under the linkage peaks.
However, for NVMSD:ALL we did not find any evidence
of LD under the linkage peaks. Considering any genomic
locations where the PPL was ≥20%, the largest PPLD|L
was less than 5%. While the small sample size may make it
difficult to detect LD under the peaks, assembling a very
large sample of families with this phenotype is difficult.
Thus, whether for underlying biological reasons or simply
due to practicalities, it does not appear that fine mapping
via LD analysis under these linkage peaks is likely to
uncover the underlying genes. For NVMSD:C, there were
13 SNPs under the NVMSD:C-specific peak on chromo-
some 4 (considering all locations where the PPL >20%)
which yielded PPLD|L >5%; the maximum PPLD|L was
Fig. 3 PPL across chromosome
17 for the NVMSD:ALL
phenotype.
Table 1 Phenotype NVMSD:ALL linkage peaks with PPL >15%.
Phenotype NVMSD:ALL (nonverbal motor speech)
Chr cM PPL Band name
chr1 180 0.74 q24.2
chr3 166 0.19 q25.31
chr4 109 0.28 q22.3
chr5 66 0.42 p12
chr5 156 0.25 q33.1
chr17 36 0.51 p12
chr17 39 0.72 p12
chr17 48 0.80 p12
chr17 55 0.44 q11.2
chr17 80 0.32 q22
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15%. However, these were distributed across a 20 cM
region, complicating the interpretation for this (even
smaller) sample. Two of these SNPs fall in genes, and one
of these genes (KDNIP4, PPLD|L=6% at rs1763197,
located at physical location 20,692,185 bp or approximately
36.6 cM) is of potential interest for its possible role in
regulation of neuronal excitability and interactions between
its protein product and presenilin.
Fig. 4 Individual chromosome PPL results for NVMSD:ALL (in black) and NVMSD:C (in red).
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IPA core analysis under linkage peaks
Using the output from the core analysis, we selectively
identified genes with functions related to Nervous System
Development and Function, Neurological Disorders, Genetic
Disorders, and Psychological Disorders. For NVMSD:ALL,
a total of 25 genes were selected from 261 genes input to
IPA for the narrow definition (highest 1% of PPLs), 52 of
645 for the intermediate definition (2.5% highest PPLs), and
62 of 1371 for the broad definition (highest 5% of PPLs).
The functions that were most represented overall were
neuronal development, myelination, and axonal guidance.
Likewise for NVMSD:C, 23 of 111 genes were selected
for the narrow definition, 51 of 388 for the intermediate
definition, and 147 of 954 for the broad definition. There
was an increase of molecules involved in axonal guidance
in NVMSD:C. Analyses for both phenotypes reported
genes involved in motor function and various psychiatric
and neurological disorders including Schizophrenia, Bipo-
lar Disorder, and Alzheimer’s disease (Supplemental
Table 3a, b).
IPA core analysis in control regions
The IPA core analysis of the C:GN (control based on gene
number) datasets resulted in a different distribution of
relevant significant functions than did the analysis of the
linkage data. In contrast to the NVMSD:ALL intermediate
analysis, each C:GN analysis resulted in several relevant
functions with at least 20 contributing genes (Supplemental
Table 4b). Likewise, the number of multi-function control
candidate genes is different in the C:GN analyses than in
our linkage analyses. In our linkage analysis, there was one
gene that contributed to 21 functions and the rest of the
genes contributed 10 functions or less (Supplemental
Table 4a). In the C:GN analyses, there were multiple genes
that contributed to more than 15 functions and the rest
contributed to 5 or less functions. The most common
functions identified in the C:GN analyses were synaptic
transmission, neurotransmission, and various psychological
disorders (Supplemental Table 4b).
To overcome the potential bias introduced by restricting
our control analysis to the relatively small percentage of the
genome with PPL values tightly centered around 2%, we
repeated this analysis using genes selected from the entire
genome (C:GNG). A similar overall pattern of significant
functions and multi-function candidate genes to the C:GN
results was seen in the C:GNG analyses (see Supplemental
Table 4c). Like the C:GN results, the most common
functions identified in the C:GNG analyses were various
psychological disorders and synaptic functionality. It
should be noted that genes identified by our linkage
analyses were not excluded from the C:GNG datasets
(Supplemental Table 4b and c).
Overall, the most common diseases seen in both control
analyses were neuropsychiatric disorders, such as Hunting-
ton’s Disease and Schizophrenia, and the most common
functions were neurotransmission/synaptic transmission
and development of neurons and neurites. The presence of
these diseases and functions in our control analyses suggest
Fig. 5 PPL results across
chromosome 4 for NVMSD:
ALL (in black) and NVMSD:C
(in red).
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that while they may be related to our phenotypes of interest,
these functions are not unique to the core analysis of our
linkage study, and may be an artifact of the extensive
published research in these areas. Interestingly, only eight
specific functions identified by the control analyses over-
lapped with those identified from the genes from our
linkage analysis. Each of these functions (cell death of
neuroglia and oligodendrocytes, learning by mice, plasticity
of synapse, survival of cortical neurons, development of
dentate gyrus, motor neurons, and peripheral nervous
system) appeared only once in the control analyses. While
there is some commonality in functions, it is important to
note that the candidate genes described below are not
implicated by functions identified in the control analyses.
Discussion
Linkage and association
We have identified several peaks that represent strong
evidence of linkage using two novel and relatively narrow
behavioral phenotypes for non-verbal language and motor
speech problems; characteristics that are associated with
autism but not exclusive to the autism spectrum. While
some of the peaks overlap with previously reported linkage
locations (Alarcón et al. 2005; Bartlett et al. 2005; Cantor et
al. 2005; McCauley et al. 2005; Schellenberg et al. 2006;
Yonan et al. 2003), others are novel. In some cases, where
results overlap, different behavioral phenotypes have been
reported for those peaks. This is not surprising since, by
definition, an individual with autism might share behaviors
and belong to several phenotypic subgroups within the
spectrum as well as share behaviors with individuals who
do not meet criteria for ASD. Additionally, there have been
multiple studies looking at language and autism using the
AGRE sample and the potential for overlapping subjects is
impossible to avoid. However, the strength of the peaks and
the specificity of the phenotype lend support to the idea that
there could be genes of interest under these peaks that
warrant further investigation.
We included all individuals from the AGRE data set who
had ADI-R diagnostic information and Affymetrix 5.0
genetic data regardless of their final ASD diagnosis. A
percentage of those identified as meeting criteria for one or
both phenotypes did not meet the ASD cut-off criteria. Yet
at some point, they must have demonstrated behaviors
compatible with a potential ASD diagnosis or they would
not have received the AGRE ASD study battery in the first
place. This lends support to the notion that in families with
ASD probands, there may be other family members that
share behavioral characteristics and genes and fall into
some kind of broader autism phenotype.
Evidence of linkage based on PPL values greater than
15% for the NVMSD:ALL phenotype was identified on
chromosomes 1q24.2, 3q25.31, 4q22.3, 5p12, 5q33.1,
17p12, 17q11.2, and 17q22. Linkage on 3q25 and 17p
supports previous findings in the same area where loci
linked to word and phrase speech delays were identified by
Alarcón et al. (2005). In that study, the authors identified a
region on chromosome 3 (126–170 cM with a peak at
147 cM) that overlaps one of our peaks and was identified
with an onset of first words phenotype. In addition, they
identified a region on chromosome 17 (13–96 cM) that
coincides with one of our peaks and is suggestive of
linkage for first words and phrases. Since delayed first
words, and/or delayed first phrases might also apply to a
number of our probands, because they are nonverbal, one
could speculate that there was overlap across our samples.
In fact, our finding at chromosome 1q24 (PPL=74%) was
located in the same region as previously reported by our
group (Bartlett et al. 2005). In the current study, 88 AGRE
families also satisfied the diagnostic criteria for the Bartlett
et al. study (i.e., the affected phenotype was based on
delayed speech onset in two affected siblings).
For many previous autism linkage studies a more
formal diagnostic phenotype was used that ranged from a
narrow definition of autistic disorder to an autism
spectrum disorder that included Asperger’s disorders
and PDD-NOS. Since we already know that a significant
number of individuals with autism can be non-verbal or
have speech that is significantly unintelligible, it is not
surprising that overlapping linkage peaks were observed.
McCauley et al. (2005) identified linkage on 17q11 for sib
pairs consisting of at least one proband with autistic
disorder and one on the spectrum. Using a broader
definition of autism, Yonan et al. (2003) identified linkage
in the same regions of 17q and 5p as our study. Studying
male-only families has been another approach (Cantor et
al. 2005; Schellenberg et al. 2006) resulting in linkage
peaks on chromosomes 4 and 17. When Schellenberg et al.
(2006) stratified their families by male-only, they identi-
fied linkage at 4q22 and Cantor et al. (2005) identified the
17q21 region (67 cM) when doing fine mapping of the
area. Similarly, our families were enriched for affected
male subjects; we had 128 male-only families with the
remaining 75 families having at least one female affected
for our phenotype, bringing our rate of affected males to
approximately 80% in our 203 families. Buxbaum et al.
(2004) identified a peak on 1q24 as well and another peak
suggestive of linkage on chromosome 4 for an obsessive-
compulsive phenotype, thus another example of over-
lapping linkage based on different phenotypes but behav-
iors that are part of the ASD profile. In summary, even
though samples varied and descriptions of phenotypes
differed, the fact that most of our linkage peaks have been
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previously identified in ASD populations, lends support to
the idea that these particular locations are a source for
continued investigation.
The NVMSD:C phenotype was created to narrow and
better define the motor-speech characteristics that are found
in a subset of individuals with ASD as well as other
individuals with speech and language impairments. It was
based on the premise that probands who have some
language comprehension but display minimal or unintelli-
gible expressive language, might belong to a phenotypic
group specifically characterized by a motor speech impair-
ment that is seen in apraxia of speech. Using these criteria
we identified similar, but weaker, linkage signals to the
NVMSD:ALL phenotype, which is not surprising given the
smaller sample. Moreover, we hypothesize that our stronger
findings with NVMSD:C on chromosomes 4p15.2,
14p15.2, and 21q22.2 might actually be better capturing
those individuals who have a more well-defined motor-
speech disorder like apraxia.
Notably, we did not find a linkage signal on 7q, a
location that has been strongly implicated in linkage and
association with both ASD and speech and language
impairments (Alarcón et al. 2008; Arking et al. 2008;
Vernes et al. 2008; Feuk et al. 2006; Lai et al. 2001). This
was true even allowing for imprinting, which has been
suggested for FOXP2 on chromosome 7 (Feuk et al. 2006)
(Supplemental Figure 2). However, imprinting gene
candidates have been reported in regions where we did
see evidence for linkage with imprinting. Luedi et al.
(2007) report maternal expression of TRIM16 (17p12),
TIAF1 (17q11.2), HOXB2 (17q21.32), and HOXB8
(17q21.32). All of these genes match the pattern of
imprinting supported by our linkage results on chromo-
some 17 and so they represent higher priority positional
candidates; the homeobox genes are of particular interest
due to their role in development patterns in the brain
(Matis et al. 2007; Grados et al. 2003; Fanarraga et al.
1997).
Potential genes of interest using IPA
NVMSD:ALL phenotype
When we used IPA to identify potential autism susceptibil-
ity genes that might fall within our linkage regions, we
identified several genes associated with translation and
transcription factors, brain development, nervous system
development, and multiple psychiatric disorders. We also
took into consideration the overlap of functions between the
control and linkage analyses. The candidate genes de-
scribed below meet our criteria for the IPA core analysis of
the linkage regions and have been filtered for overlap with
the control analysis functions.
Our linkage region on 4q22.3 contains NKX6-1, which
encodes a transcription factor that binds to AT-rich regions
in the promoters of its target genes. NKX6-1 plays an
important role in differentiation of motor neurons and the
regulation of muscle nerve formation (Lee and Pfaff 2001;
Bohl et al. 2008; De Marco Garcia and Jessel 2008). Six
gene targets of NKX6-1 (ATOX1, GPX2, HIF1A, HMOX2,
IGFBP4, and PHB) fall within the broad linkage regions for
the NVMSD:ALL analysis and one gene (ANAPC4) falls
within the broad linkage regions for the NVMSD:C
analysis.
The linkage peak on 5p (66 cM) contains GHR, which
encodes a growth hormone receptor shown to be involved
in brain development and neuronal differentiation (Harvey
et al. 2001; Harvey et al. 2002; Ransome et al. 2004;
Buadet et al. 2007). A second linkage peak on 5q (154–
156 cM) contains two candidate genes: DPYSL3, which is
involved in neurite outgrowth and guidance and shows a
decreased expression in individuals with Down syndrome
(Weitzdoerfer et al. 2001) and HTR4, which is a serotonin
receptor that has been associated with Schizophrenia,
Attention-Deficit Hyperactivity Disorder, and Bipolar Dis-
order (Hirata et al. 2010; Suzuki et al. 2003; Hayden and
Nurnberger 2006; Elia et al. 2009). The regions on 17p and
17q contain NCOR1 and NOS2, which are involved in
NOTCH signaling and the NOS pathway, respectively.
NOS2, in particular, has been implicated in various
neurological disorders such as Alzheimer’s disease, and
Amyotrophic Lateral Sclerosis (Colton et al. 2009; Chen et
al. 2010). The peak at 17p12 (PPL=77%) also contains
PMP22, which encodes a protein that comprises 2–5% of
peripheral nervous system myelin. Most recently, Pinto et
al. (2010) identified a rare maternally inherited copy
number variation (CNV) that contains PMP22 in an
individual with ASD, however this CNV was not experi-
mentally validated.
NVMSD:C phenotype
Our linkage analysis of NVMSD:C resulted in two novel
regions, which we further investigated with the core analysis
in IPA. Overall, there was a notable increase in genes involved
in Down syndrome, which is primarily due to the inclusion of
21q22.2. IPA identified two genes on chromosome 4 involved
in axonal guidance: SLIT2 (Hammond et al. 2005) and
CRMP1 (Yamashita et al. 2006). SLIT2 is of particular
interest as both the SLIT1 and SLIT2 proteins have been
identified as selective inhibitors and repellents for dorsally
projecting cranial motor axons (Colton et al. 2009). In
addition to these axonal guidance genes, the core analysis
also identified STIM2 on chromosome 4 (45 cM, PPL=
88%), which regulates calcium entry into neurons (Berna-
Erro et al. 2009). Like the NVMSD:ALL analysis, molecules
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involved in psychiatric disorders such as Schizophrenia,
Panic Disorder, and Social Impairment were also identified
as genes involved in the NOTCH Signaling and NOS
pathways. Both analyses identified molecules that are
involved in motor function, however IPA analysis of
NVMSD:C did not produce significant findings within
regions of our strongest linkage signals.
IPA control analyses
Our control analyses (C:GN and C:GNG) served as a test of
the reliability of our IPA analysis which we will use to guide
our future investigations of autism genes. As seen in
Supplemental Table 4b and c, the numbers of functions and
candidate genes obtained for the C:GN and C:GNG analyses
were comparable to those obtained in our linkage regions.
The functions identified by IPA are not presented in a
hierarchical order, which leads to the identification of several
similar functions that are, in fact, subsets of one overall
function. This is seen commonly in our control analyses (as
demonstrated in analysis 9, Supplemental Table 4b) and also
occurs in our linkage analyses. While there was some
overlap in general function categories, there were only eight
specific functions identified in the control analyses that were
also identified in the linkage analysis. Despite this overlap in
functions, viable candidate genes were identified from the
core analysis of our linkage regions after filtering for these
common functions. This filtering of the linkage analysis
helps to ensure that the functions and genes/molecules
identified in the core analysis of the linkage regions are
unique to that analysis. Overall, the IPA core analysis used in
this study functions primarily as a data reduction tool and
was effective in identifying genes in our linkage analysis that
require further investigation.
One limitation of this study concerns the variables
available to us from the AGRE data set to define a motor
speech disorder. To make a clinical diagnosis of such a
disorder, a speech language pathologist would use con-
verging information including an extensive language
history, a complete oral motor exam, and a comprehensive
speech and language assessment that would include specific
information about the phonological abilities of each
proband. Yet, our strong linkage findings suggest that at
this stage of investigation we have defined this disorder
well enough to continuing pursuing the genes, gene
interactions, and gene variants under the peaks.
Conclusion
We have identified several unique loci, based on two
specific motor speech phenotypes, that are present in, but
not exclusive to, a subset of individuals within families
with autism spectrum disorders. In addition, we have
identified several loci that had been previously isolated on
the basis of somewhat different diagnostic criteria. Family
members who are non-verbal or verbal but have speech that
is unintelligible may or may not meet criteria for ASD but
may share genes and behaviors that are also seen in other
speech and language disorders. Although we found no
compelling evidence of association under our linkage
peaks, we were able to suggest genes for further investiga-
tion based on their biological functions using IPA. It is well
recognized that autism spectrum disorders are complex with
a wide range of behaviors and, potentially, a large number
of underlying genes, so that these particular sets of
behaviors might fall into a broader phenotype and further
emphasize the need to develop narrow well-defined
phenotypes to reduce genetic heterogeneity.
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